Physician profile
Daniel Aaron Hatef
NPI 1477884070
$673,067.26
in general payments reported to CMS, 2019-2025
17 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $656K · 2021: $937 · 2022: $4,065 · 2023: $10K · 2024: $254 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $1,040 · Travel and Lodging: $28.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $1,040.04 |
| Travel and Lodging | $28.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $656,766.30 | 2019-2021 | |
| Tela Bio, INC. | $10,149.78 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $4,461.98 | 2019-2022 | |
| Abbvie INC. | $576.52 | 2023-2025 | |
| Revance Therapeutics, INC. | $270.74 | 2024-2025 | Daxxify |
| Tepha INC | $222.04 | 2019 | |
| Galderma Laboratories, L.P. | $219.31 | 2021-2024 | |
| Bard Peripheral Vascular, INC. | $110.96 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $62.47 | 2021-2024 | |
| Mentor Worldwide LLC | $59.19 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Merz North America, INC. | $44.06 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $40.43 | 2022-2023 | |
| Bsn Medical INC | $24.11 | 2025 | |
| Alpha Orthopedic Systems | $18.70 | 2024 | |
| Mimedx Group, INC. | $15.25 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $13.46 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hatef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.